A carregar...
Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with statin and ezetimibe therapy, and those with homozygous FH (HoFH) usually require a...
Na minha lista:
| Publicado no: | Endocrinol Metab (Seoul) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Endocrine Society
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090480/ https://ncbi.nlm.nih.gov/pubmed/33866776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2021.964 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|